TXG
10x Genomics, Inc.
$57.07+0.77 (+1.37%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Sep 12, 2019 – Nov 18, 2026, Dividends reinvested
- Final balance
- $10,819
- CAGR
- +1.10%
- Max drawdown
- −96.47%
Trailing returns (%)
TXG's average annual return was −17.55% over the last 5 years, through Nov 18, 2026. $10,000 in TXG on Nov 18, 2021 fell to $3,811 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −18.31%
- 3M
- +2.59%
- 6M
- +166.06%
- YTD
- +249.91%
- 1Y
- +266.77%
Per year
- 3Y
- +10.61%
- 5Y
- −17.55%
- Since 2019
- +1.10%
Annual returns
2019 from Sep 12 · 2026 through Nov 18
TXG returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +249.91% |
| 2025 | +13.58% |
| 2024 | −74.34% |
| 2023 | +53.57% |
| 2022 | −75.54% |
| 2021 | +5.20% |
| 2020 | +85.70% |
| 2019 from Sep 12 | +44.55% |
Metrics
Since 2019| Volatility | 68.17% |
|---|---|
| Sharpe ratio | 0.36 |
| Sortino ratio | 0.52 |
| Calmar ratio | 0.01 |
| Longest drawdown | 5.6 years |
Worst drawdowns
Since 2019| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −96.5% | Apr 2021 | Apr 2025 | Not yet | 5.6 years so far |
| −51.6% | Jan 2020 | Mar 2020 | Aug 2020 | 7 months |
| −28.3% | Feb 2021 | Mar 2021 | Apr 2021 | 2 months |
| −25.7% | Sep 2019 | Oct 2019 | Nov 2019 | 2 months |
| −21.2% | Oct 2020 | Nov 2020 | Jan 2021 | 3 months |